Profusa (NVACW) Receivables - Other (2021 - 2022)
Profusa posted quarterly Receivables - Other of $25000.0 for Q1 2022, little changed on a QoQ basis from $25000.0 in Q4 2021.
Profusa (NVACW) has 2 years of Receivables - Other data on file, last reported at $25000.0 in Q1 2022.
- For the quarter ending Q1 2022, Receivables - Other changed N/A year-over-year to $25000.0; the trailing twelve-month figure through Mar 2022 stood at $25000.0 (changed N/A YoY), and the FY2021 full-year result was $25000.0, changed N/A from the prior year.
- Receivables - Other for Q1 2022 stood at $25000.0, roughly flat from $25000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $25000.0 in Q4 2021 and bottomed at $25000.0 in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Profusa | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 25,000.00 |
| Mar 31, 2022 | 25,000.00 |
| Dec 31, 2021 | 25,000.00 |
| Dec 31, 2021 | 25,000.00 |